Amref Kenya Partners with Sisu Global Health and Surgipharm to improve access to blood

by Amref Health Africa

Amref Health Africa in Kenya and Sisu Global Health and Surgipharm on Tuesday unveiled a partnership to improve access to blood and safer surgical outcomes during medical missions and emergencies in Kenya.

The partnership is aimed at increasing blood access in all hospitals to reduce internal bleeding-related deaths through the adoption of Hemafuse TM, an innovative medical device that allows clinicians to reuse a patient’s own blood gathered from internal bleeding.

This initiative comes in the wake of the recent move by the US President’ s Emergency Plan for Aids Relief (PEPFAR) to stop its annual funding of KShs2 billion for blood collection and testing services in Kenya. The development also comes at a time when the country is facing a chronic shortage of blood as the collection of blood has been plagued by the lack of funds for screening tools and human resources to collect and store blood.

“Blood access is critical to safe surgery. Standard surgical practices require two units of blood on-hand before surgery commences, but there is a severe shortage of blood in the country. Surgeries may be delayed or not performed due to a lack of blood, resulting in increased illness and death,” said Amref Health Africa in Kenya’s Country Director, Dr. Meshack Ndirangu.

“This partnership will make use of an innovative solution that will ensure that patients with internal bleeding have a chance of survival.”

Hemafuse TM, a product by Sisu Global Health, can filter and pump blood from an internal haemorrhage into a blood bag, allowing it to be re-transfused to the same patient. The device can also be reused up to 25 times. This provides an alternative to donor blood.

“It is inspiring to see Hemafuse TM used to save lives. With this partnership, we look forward to enabling thousands more clinicians to save more lives across the country. The work we are doing is incredibly important, and we are proud to have such a strong partnership with Amref and Surgipharm to provide access to blood across Kenya,” said Sajju Jain, Chief Operating Officer at Sisu Global Health.

Speaking at the event, Mr. Rakesh Vinayak, Director-Sales & Marketing at Surgipharm, said that the pharmaceutical industry has a critical role to play in finding effective and sustainable solutions to providing access to today’s most pressing health concerns.

“Surgipharm has a highly specialised and experienced management team and our relationships with different players in Kenya’s health sector,” he said.

Article first published on

You may also like

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More